Category: About LabKey

10 Jan 2017

Looking Forward: 2017 at LabKey

As we move forward into a new year, the LabKey team is excited to share our vision for 2017 with the LabKey community. Key priorities for this year include:

LabKey Biologics - Entity registration, assay integration and workflow management for biotherapuetic researchLaunching LabKey Biologics

March 2017 will mark a very exciting milestone as we release our new product, LabKey Biologics. Thanks to the close partnership that we have had with Just Biotherapeutics and feedback we have received from members of the biotech community that participate in our Product Advisory Council, this product is prepared to help biologic research and development teams optimize their workflows and extract valuable insights from their data.

Improving the LabKey Server User Experience

In working with teams using LabKey Server and hearing the great feedback from users at the LabKey User Conference, we determined there is a need to make changes to improve the LabKey Server user experience. In 2017, we will be investing time into upgrading the platform’s UI in order to make LabKey Server easier to install and use more effectively.

Extending Compliance Capabilities in LabKey Server

This year, the LabKey team will also be focusing on expanding the capabilities of LabKey Server to better support regulatory compliance as well as providing compliant hosting services. Support for electronic signatures, enhanced functionality to protect PHI, and new FISMA compliance features will be added in 2017 to extend LabKey Server support for regulatory compliance.

In addition to our focus areas, LabKey will continue to make platform enhancements to support the bioinformatics needs of our users. We are looking forward to another great year working with the LabKey community and supporting the incredible work being conducted by our partners!

07 Apr 2016

Value in Cancer Care Summit 2016

Last week, members of the LabKey team took a break from the office to attend the 2016 Value in Cancer Care Summit, hosted by our partners at the Hutchinson Institute for Cancer Outcomes Research (HICOR). The summit serves as a forum for individuals from across the healthcare spectrum to convene and collaborate on ways to improve the value and efficiency of cancer care delivery. The event included an introduction to HICOR’s methodology for evaluating costs and an overview of regional cost metrics presented by Fred Hutch’s Scott Ramsey, MD, PhD, as well as a series of intervention working groups where patients, clinicians, and researchers came together to discuss how best to improve care in the areas of end-of-life intervention, breast cancer surveillance intervention, and hospitalization during treatment intervention.

Attendees also got the opportunity to explore HICOR IQ, HICOR’s database of population-based cancer incidence, survival information, and insurance claims data that gives regional partners continuously updated reporting of trends in oncology. With HICOR IQ, users can select their metrics of interest and configure plots based on regional or clinic views, as well as breakdowns by age, cancer site, or stage. HICOR IQ is a LabKey Server-based application that was developed by LabKey in collaboration with HICOR.

Hearing first hand about the challenges being faced in cancer care helps the LabKey team better understand how we can provide tools to help solve them. We are looking forward to seeing the impact of HICOR’s great work as they harness the power of integrated data to help improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer—ultimately leading to better outcomes for patients.

Related Resources

HICOR IQ Datasheet